The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Recently the Food and Drug Administration (FDA) required new safety measures for oral sodium phosphate products to reduce the risk of acute kidney injury. The risk is associated with both prescription and over-the-counter products. The most popular brand is Fleet Phospho-soda, produced by C.B. Fleet Co. as a laxative doctors commonly recommend for colonoscopy preparation. Before taking this drug, remember to ask about its association with kidney failure.

Symptoms of kidney failure can include high blood pressure, irregular heartbeat, fluid retention, muscle twitching, and seizures. One of the biggest risk factors is dehydration. The Fleet Company is on record saying the product has been on the market for over 100 years and when used properly, in the proper patients, and with enough hydration, the drug is safe.

If you are taking this medication, do not double dose. Tell your doctor if you begin vomiting, feel dizzy, have decreased urination, or have trouble drinking liquids.

Comments are closed.

Of Interest